Page 343 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 343
P1313 WTX101-201: PHASE 2 STUDY OF BIS-CHOLINE ePOSTERS
P1314 TETRATHIOMOLYBDATE IN NEWLY DIAGNOSED WILSON
P1315 DISEASE PATIENTS
Karl Heinz Weiss*, Fred Askari, Peter Ferenci, Anna Czlonkowska,
P1316 Jeff Bronstein, David Clark, Jonas Hansson, Michael Schilsky, Germany
YI P1317 GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF)
TO TREAT ACUTE-ON-CHRONIC LIVER FAILURE: A
MULTICENTER RANDOMIZED TRIAL (GRAFT STUDY)
Cornelius Engelmann*, Oana Brosteanu, Hannelore Tenckhoff,
Katrin Splith, Moritz Schmelzle, Thomas Berg, Germany
DESIGN OF THE INCA TRIAL (IMPACT OF NOD2
GENOTYPE-GUIDED ANTIBIOTIC PREVENTION ON
SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS AND
ASCITES): PROSPECTIVE, DOUBLE-BLIND, RANDOMISED
CLINICAL TRIAL EVALUATING THE IMPACT OF
GENOTYPE-STRATIFIED CARE
Markus Casper, Martin Mengel, Christine Fuhrmann, Eva Herrmann,
Matthias Reichert, Beate Appenrodt, Frank Grünhage, Frank Lammert*,
Germany
EFFECTS OF LONG-TERM ADMINISTRATION OF
MIDODRINE AND ALBUMIN IN THE PREVENTION
OF COMPLICATIONS IN PATIENTS WITH CIRRHOSIS
ON WAITING LIST FOR LIVER TRANSPLANTATION.
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND,
PLACEBO-CONTROLLED TRIAL. MACHT STUDY
Elsa Sola*, Macarena Simon Talero, Marta Martin-Llahi, Jose Castellote,
Andre Nazar, Cristina Solè, Meritxell Ventura, Raquel Cela,
Nuria Fabrellas, Maria Torrens, Eva Lopez, Gloria de Prada,
Patricia Huelin, Pilar Suñé, Monica Guevara, Xavier Xiol, Victor Vargas,
Vicente Arroyo, Pere Gines, Spain
EFFICACY OF URSODEOXYCHOLIC ACID AS A VOLUME
REDUCING TREATMENT FOR SYMPTOMATIC POLYCYSTIC
LIVER DISEASE: AN INTERNATIONAL, MULTICENTER,
RANDOMIZED CONTROLLED TRIAL
Hedwig M. D’Agnolo*, Tom J. Gevers, Ioana Riaño, Luis Bujanda,
Bart Takkenberg, Ulrich Beuers, Jesus M. Banales, Joost P. Drenth,
The Netherlands
Vienna, Austria • April 22–26, 2015 343
P1314 TETRATHIOMOLYBDATE IN NEWLY DIAGNOSED WILSON
P1315 DISEASE PATIENTS
Karl Heinz Weiss*, Fred Askari, Peter Ferenci, Anna Czlonkowska,
P1316 Jeff Bronstein, David Clark, Jonas Hansson, Michael Schilsky, Germany
YI P1317 GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF)
TO TREAT ACUTE-ON-CHRONIC LIVER FAILURE: A
MULTICENTER RANDOMIZED TRIAL (GRAFT STUDY)
Cornelius Engelmann*, Oana Brosteanu, Hannelore Tenckhoff,
Katrin Splith, Moritz Schmelzle, Thomas Berg, Germany
DESIGN OF THE INCA TRIAL (IMPACT OF NOD2
GENOTYPE-GUIDED ANTIBIOTIC PREVENTION ON
SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS AND
ASCITES): PROSPECTIVE, DOUBLE-BLIND, RANDOMISED
CLINICAL TRIAL EVALUATING THE IMPACT OF
GENOTYPE-STRATIFIED CARE
Markus Casper, Martin Mengel, Christine Fuhrmann, Eva Herrmann,
Matthias Reichert, Beate Appenrodt, Frank Grünhage, Frank Lammert*,
Germany
EFFECTS OF LONG-TERM ADMINISTRATION OF
MIDODRINE AND ALBUMIN IN THE PREVENTION
OF COMPLICATIONS IN PATIENTS WITH CIRRHOSIS
ON WAITING LIST FOR LIVER TRANSPLANTATION.
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND,
PLACEBO-CONTROLLED TRIAL. MACHT STUDY
Elsa Sola*, Macarena Simon Talero, Marta Martin-Llahi, Jose Castellote,
Andre Nazar, Cristina Solè, Meritxell Ventura, Raquel Cela,
Nuria Fabrellas, Maria Torrens, Eva Lopez, Gloria de Prada,
Patricia Huelin, Pilar Suñé, Monica Guevara, Xavier Xiol, Victor Vargas,
Vicente Arroyo, Pere Gines, Spain
EFFICACY OF URSODEOXYCHOLIC ACID AS A VOLUME
REDUCING TREATMENT FOR SYMPTOMATIC POLYCYSTIC
LIVER DISEASE: AN INTERNATIONAL, MULTICENTER,
RANDOMIZED CONTROLLED TRIAL
Hedwig M. D’Agnolo*, Tom J. Gevers, Ioana Riaño, Luis Bujanda,
Bart Takkenberg, Ulrich Beuers, Jesus M. Banales, Joost P. Drenth,
The Netherlands
Vienna, Austria • April 22–26, 2015 343
